GENEART Supports iGEM Contest for the Third Year in a Row
News Jun 24, 2009
GENEART AG supports the international iGEM (International Genetically Engineered Machine) contest for applications in Synthetic Biology for the third time in a row.
Student teams spend their summer holidays constructing, with the help of standardized exchangeable building blocks from DNA (DNA: deoxyribonucleic acid/genetic material), for instance bacteria with which cancer cells can be specifically destroyed or environmental toxins such as arsenic can be detected and degraded.
According to GENEART, this year 112 international teams, each under the direction of leading scientists in the area of Synthetic Biology, compete for the most innovative idea. The contest has seen a rapid development since its inauguration in 2004 and is now considered to be one of the largest international scientific competitions
All DNA building blocks developed within the scope of iGEM to date - by now more than 1,000 - are collected in a kind of library and are available to all iGEM teams for their projects as well. The goal of the contest is to combine already existing DNA building blocks with self developed constructions and thus create complex bio-systems with new functions.
As partner of the contest, GENEART will provide 280.000 base pairs to the participants to produce new DNA fragments. At the same time, GENEART provides financial support for the competition. The prizes are presented in October at the iGEM award ceremony at the campus of the Massachusetts Institute of Technology (MIT) in Cambridge, MA (USA).
APC Protein Deletion Disrupts Cell Signalling and Could Cause AutismNews
Researchers show deletion of the protein APC in progenitor cells leads to massive disruption of brain development and a signaling cascade previously linked to genes associated with autism.READ MORE
The Ancient Behaviour of Sleep, Conserved Throughout EvolutionNews
The finding that jellyfish sleep implies that sleep is an ancient behavior, largely untouched by millennia of evolution.READ MORE
Gene Immunotherapy Approach Prevents and Reverses Symptoms of Multiple SclerosisNews
Researchers used a viral vector to deliver a gene encoding a myelin sheath protein to the liver, thereby inducing robust and durable immune tolerance in mice by preventing T cells from attacking the myelin sheath.READ MORE